Page last updated: 2024-11-04

sibutramine and Heart Valve Diseases

sibutramine has been researched along with Heart Valve Diseases in 6 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research Excerpts

ExcerptRelevanceReference
" This review addresses the following three topics: a brief discussion of older weight loss medications approved for short-term use (benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine), as well as over-the-counter adrenergic drugs (phenylpropanolamine and ephedrine); recent clinical studies documenting the safety and efficacy of a new medication for obesity treatment, sibutramine, recently approved by the Food and Drug Administration for long-term use; and recent studies characterizing the valvulopathy associated with fenfluramine and dexfenfluramine, serotonergic medications for obesity which have been removed from the markets."8.80Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. ( Ryan, DH, 2000)
" In the late sixties, aminorex caused an epidemic of pulmonary hypertension with high mortality rates."4.80[Obesity: principles of drug therapy]. ( Ballmer, PE; Imoberdorf, R, 2000)
" This review addresses the following three topics: a brief discussion of older weight loss medications approved for short-term use (benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine), as well as over-the-counter adrenergic drugs (phenylpropanolamine and ephedrine); recent clinical studies documenting the safety and efficacy of a new medication for obesity treatment, sibutramine, recently approved by the Food and Drug Administration for long-term use; and recent studies characterizing the valvulopathy associated with fenfluramine and dexfenfluramine, serotonergic medications for obesity which have been removed from the markets."4.80Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. ( Ryan, DH, 2000)
" Sibutramine is a new anorectic drug used for the treatment of obesity."3.71[Study of heart valve function on obese patients treated with sibutramine]. ( Astorga, R; García-Luna, PP; López-Pardo, F; Parejo, J; Pereira, JL; Rodríguez-Puras, MJ, 2002)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saraç, S1
Saraç, F1
Gonzálvez Perales, JL1
Catalán Oliver, C1
Belenguer Varea, A1
Imoberdorf, R1
Ballmer, PE1
Ryan, DH1
Pereira, JL1
López-Pardo, F1
Parejo, J1
Astorga, R1
Rodríguez-Puras, MJ1
García-Luna, PP1

Reviews

2 reviews available for sibutramine and Heart Valve Diseases

ArticleYear
[Obesity: principles of drug therapy].
    Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:8

    Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyc

2000
Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.
    Endocrine, 2000, Volume: 13, Issue:2

    Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Dexfenfluramine; Dextroamphetamine; Fenfluram

2000

Trials

1 trial available for sibutramine and Heart Valve Diseases

ArticleYear
Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2010, Volume: 10, Issue:3

    Topics: Adipokines; Adiponectin; Adult; Appetite Depressants; C-Reactive Protein; Cyclobutanes; Diabetes Com

2010

Other Studies

3 other studies available for sibutramine and Heart Valve Diseases

ArticleYear
[Cardiac safety and sibutramine].
    Medicina clinica, 2002, Sep-21, Volume: 119, Issue:9

    Topics: Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Heart Valve Diseases; Humans

2002
Studies confirm link between fen-phen and heart-valve disease.
    Harvard heart letter : from Harvard Medical School, 1998, Volume: 9, Issue:4

    Topics: Appetite Depressants; Cyclobutanes; Dexfenfluramine; Drug Combinations; Fenfluramine; Heart Valve Di

1998
[Study of heart valve function on obese patients treated with sibutramine].
    Medicina clinica, 2002, Jan-26, Volume: 118, Issue:2

    Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Heart Valve Diseases; Humans; Male; Middle Aged;

2002